Global Blood Plasma Derivatives Market Size and Forecast 2024-2033|Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited

The Blood Plasma Derivatives Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Blood Plasma Derivatives Market:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

According to The Business Research Company’s Blood Plasma Derivatives Global Market Report 2024, The blood plasma derivatives market size has grown strongly in recent years. It will grow from $48.26 billion in 2023 to $52.61 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services.

The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $75 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation.

The increasing prevalence of immunodeficiency disorders is expected to drive the growth of the blood plasma derivatives market. Immunodeficiency disorders are illnesses that either completely or partially compromise the immune system. Blood plasma derivatives find application in treating a multitude of medical conditions, including immune deficiency disorders. Plasma, a solution consisting of proteins and salts, encompasses over 100 different proteins, among which immunoglobulins are particularly utilized for addressing primary immunodeficiencies. Poor nutrition or malnutrition leads to macro- and micronutrient deficiencies, which can lead to immunodeficiency. For instance, in July 2022, according to another report shared by WHO, globally, 828 million people were impacted by hunger in 2021. Hunger is a major contributor to malnutrition. Therefore, the increasing prevalence of immune deficiency disorders is driving the growth of the blood plasma derivatives market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Major companies operating in the blood plasma derivatives market are focused on adopting strategic partnerships to gain a competitive edge in the market. With this partnership, patients in need will have access to a steady and dependable supply of these vital plasma-derived medications, helping to meet the increasing need for immunoglobulins in France and beyond. For instance, in January 2022, Kedrion S.p.A. an Italy-based biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies partnered with LPB, a UK-based pharmaceutical company specializing in biological medicinal products. Kedrion will use LFB plasma obtained in France by the Etablissement Français du Sang (EFS) to produce immunoglobulins in Hungary. The current supply of immunoglobulins, which will be made available to hospitals across the nation in accordance with and under the supervision of French health authorities, will be supplemented by these imports from LFB in France.

The blood plasma derivatives market report table of contents includes:

1. Executive Summary

2. Blood Plasma Derivatives Market Characteristics

3. Blood Plasma Derivatives Market Trends And Strategies

4. Blood Plasma Derivatives Market – Macro Economic Scenario

5. Global Blood Plasma Derivatives Market Size and Growth

26. South America Blood Plasma Derivatives Market

27. Brazil Blood Plasma Derivatives Market

28. Middle East Blood Plasma Derivatives Market

29. Africa Blood Plasma Derivatives Market

30. Blood Plasma Derivatives Market Competitive Landscape And Company Profiles

Top Major Players: